AbbVie will invest $1.4 billion to build a pharmaceutical park in North Carolina, USA.

AbbVie announced on April 22nd to invest $1.4 billion in building a pharmaceutical park in North Carolina, USA, integrating advanced manufacturing and laboratory technology as well as artificial intelligence to support the production of the company's immunology, neuroscience, and oncology drugs. The park is scheduled to start construction this year and expected to be completed by the end of 2028.